The Global Biotechnology (Pharmaceuticals) ReportPlimsoll Publishing Ltd.September 24, 2009 500 Pages - SKU: PLSL2443897 |
|
Gilead Sciences, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Gilead Sciences, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Gilead Sciences, Inc. - Product Pipeline Review - 2012” provides data on the Gilead Sciences, Inc.’s research and development focus. The report
|
more...
|
$500.00
|
|
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.
Comprehensive directory of royalty financing deals
|
more...
|
$2,695.00
|
|
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.
|
more...
|
$2,695.00
|
|
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than
|
more...
|
$3,000.00
|
|
Global Biotechnology
4/4/2012 | published by: IBISWorld
Global Biotechnology Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living materials for the production of knowledge and biotechnology products and
|
more...
|
$935.00
|
|
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical market in the US covering various aspects such as market
|
more...
|
$850.00
|
|
Global Biosimilars Market Forecast to 2015
3/1/2012 | published by: RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to
|
more...
|
$1,500.00
|
|
Genencor in Ingredients (World)
3/7/2012 | published by: Euromonitor International
Genencor, which was acquired by DuPont in 2011 and now forms that company’s new Industrial Biosciences division, is one of the largest biotechnology operations in the world. This profile assesses the company’s structure, strategies and
|
more...
|
$520.00
|
|
Biologics Market in Brazil
3/2/2012 | published by: Frost & Sullivan
This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon,
|
more...
|
$6,000.00
|
|
Top 472 Biotechnology (Pharmaceuticals) (Global)
4/1/2012 | published by: Plimsoll Publishing Ltd.
This report is an in-depth financial evaluation of the GlobalBiotechnology (Pharmaceuticals). Using the unique Plimsoll method of analysis, each of the top 472 companies included is individually assessed and ranked against each other and compared
|
more...
|
$1,500.00
|
